[The therapeutic potentials of Berotec-100 in bronchial asthma patients].
Emel'ianov
A V
AV
Shevelev
S E
SE
Shubin
S A
SA
Sinitsina
T M
TM
Fedoseev
G B
GB
D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D005280:Fenoterol / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D005280:Fenoterol